EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)

Theragnostic Gadolinium-Based Nanoparticles Safely Augment X-ray Radiation Effects in Patients with Cervical Cancer

Cyrus Chargari, Pauline Maury, Matthieu Texier, Catherine Genestie, Philippe Morice, Sophie Bockel, Sébastien Gouy, Mouhamadou Ba, Samir Achkar, François Lux, Olivier Tillement, Sandrine Dufort und 12 weitere

ACS Nano · 02.07.2024 · 18 (26) · 16516-16529

DOI: 10.1021/acsnano.3c12537 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift ACS Nano, online erschienen am 24.06.2024. Verfasst von Cyrus Chargari und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif 94805, France. Hauptthemen laut MEDLINE: Gadolinium, Uterine Cervical Neoplasms, Nanoparticles, Magnetic Resonance Imaging. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Institut National Du Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GadoliniumUterine Cervical NeoplasmsNanoparticlesMagnetic Resonance ImagingHumansFemaleMiddle AgedBrachytherapyContrast MediaX-RaysAdultAgedChemoradiotherapy

Stichwörter der Autor:innen

brachytherapycervical cancergadolinium-based nanoparticlesphase Iradiation oncologyradiotherapytheragnostics

Substanzen

GadoliniumContrast Media

Autor:innen und Institutionen

  • Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif 94805, France.
  • INSERM1030 Molecular Radiotherapy and Therapeutic Innovation Gustave Roussy Cancer Campus, Villejuif 94805, France.
  • Biostatistics Unit, Gustave Roussy Cancer Campus, Villejuif 94805, France.
  • Department of Pathology, Gustave Roussy Cancer Campus, Villejuif 94805, France.
  • Department of Surgery, Gustave Roussy Cancer Campus, Villejuif 94805, France.
  • Institut Lumière-Matière, UMR 5306, Université Lyon1-CNRS, Université de Lyon, Villeurbanne Cedex 69622 Villeurbanne, France.

ORCID-Profile: Eric Deutsch

Förderung

  • Institut National Du Cancer

Zitieren

APA

Chargari, C., Maury, P., Texier, M., Genestie, C., Morice, P., Bockel, S., Gouy, S., Ba, M., Achkar, S., Lux, F., Tillement, O., Dufort, S., Duc, G. L. E., Debeaumont, O., Massard, C., Maulard, A., Porcel, E., Bahleda, R., Ammari, S., …, & Deutsch, E. (2024). Theragnostic Gadolinium-Based Nanoparticles Safely Augment X-ray Radiation Effects in Patients with Cervical Cancer. ACS Nano, 18(26), 16516-16529. https://doi.org/10.1021/acsnano.3c12537

Vancouver

Chargari C, Maury P, Texier M, Genestie C, Morice P, Bockel S, et al. Theragnostic Gadolinium-Based Nanoparticles Safely Augment X-ray Radiation Effects in Patients with Cervical Cancer. ACS Nano. 2024;18(26):16516-16529. doi:10.1021/acsnano.3c12537

BibTeX
@article{Chargari2024,
  author = {Chargari, Cyrus and Maury, Pauline and Texier, Matthieu and Genestie, Catherine and Morice, Philippe and Bockel, Sophie and Gouy, Sébastien and Ba, Mouhamadou and Achkar, Samir and Lux, François and Tillement, Olivier and Dufort, Sandrine and Duc, Géraldine L E and Debeaumont, Olivier and Massard, Christophe and Maulard, Amandine and Porcel, Erika and Bahleda, Ratislav and Ammari, Samy and Morel, Daphné and Espenel, Sophie and Pautier, Patricia and Robert, Charlotte and Deutsch, Eric},
  title = {Theragnostic Gadolinium-Based Nanoparticles Safely Augment X-ray Radiation Effects in Patients with Cervical Cancer},
  journal = {ACS Nano},
  year = {2024},
  volume = {18},
  number = {26},
  pages = {16516--16529},
  doi = {10.1021/acsnano.3c12537}
}
Kostenlos starten →